Daily home fortification with iron as ferrous fumarate versus NaFeEDTA: a randomised, placebo-controlled, non-inferiority trial in Kenyan children

BACKGROUND: We aimed to show the non-inferiority of home fortification with a daily dose of 3 mg iron in the form of iron as ferric sodium ethylenediaminetetraacetate (NaFeEDTA) compared with 12.5 mg iron as encapsulated ferrous fumarate in Kenyan children aged 12–36 months. In addition, we updated...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:BMC Med
Auteurs principaux: Teshome, Emily M., Andang’o, Pauline E. A., Osoti, Victor, Terwel, Sofie R., Otieno, Walter, Demir, Ayşe Y., Prentice, Andrew M., Verhoef, Hans
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2017
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5408380/
https://ncbi.nlm.nih.gov/pubmed/28449690
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12916-017-0839-z
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires